Envveno Medical (NVNO)Director bought ~$24K

~$24K

Approx. value · 9,620 sh @ $2.53

17K

Holds after · shares reported

Traded

Dec 19, 2024

Filed

Dec 23, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 19, 2024 · this disclosureInsiderDirector purchased ~$24K of NVNO shares in the open market

What came next

1. Dec 19, 2024InsiderCEO purchased ~$31K of NVNO shares in the open market
2. Dec 24, 2024InsiderDirector purchased ~$16K of NVNO shares in the open market
3. Dec 31, 2024Insider · 2 peopleInsiders: 2 purchases (~$260K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Envveno Medical

OQRO holds no insider, Congress, fund or contract record for Envveno Medical dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NVNO page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Envveno Medical

• SEC Form 4Sep 17, 2025
• SEC Form 4Jan 3, 2025
• SEC Form 4Jan 2, 2025
• SEC Form 4Dec 26, 2024
• SEC Form 4Dec 20, 2024

Everything OQRO holds on this company is on its NVNO page.